Showing results (71-80 of 275) with videos related to
Sort By:
Pageof 28
Gastroenterology & Hepatology|April 9, 2014
Sodium benzoate for treatment of hepatic encephalopathyMichael L Misel, Robert G Gish, Heather Patton, et al.The Lancet. Infectious Diseases|February 14, 2012
Selection of chronic hepatitis B therapy with high barrier to resistanceRobert Gish, Ji-Dong Jia, Stephen Locarnini, et al.Seminars in Cancer Biology|September 10, 2013
Possible origins and evolution of the hepatitis B virus (HBV)Stephen Locarnini, Margaret Littlejohn, Muhammad Nazri Aziz, et al.Gastroenterology & Hepatology|March 17, 2012
Integrating recent data in managing adverse events in the treatment of hepatocellular carcinomaRobert G Gish, Ghassan K Abou-Alfa, Myron J TongJournal of Clinical Gastroenterology|February 15, 2019
More Severe Deficits in Performance Status at Time of Liver Transplant is Associated With Significantly Higher Risk of Death Following Liver TransplantationPatrick McCabe, Robert G Gish, Ramsey Cheung, et al.Drugs|June 30, 2017
Drugs in Development for Hepatitis BAltaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, et al.Journal of Hepatology|April 29, 2015
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsStephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, et al.Therapeutic Advances in Gastroenterology|November 3, 2016
Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney diseaseAnita Kohli, Ali Alshati, Fawaz Georgie, et al.The American Journal of Gastroenterology|July 31, 2007
A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis BRobert G Gish, Daryl T-Y Lau, Peter Schmid, et al.The American Journal of Medicine|March 29, 2021
Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver DiseaseRobert J Wong, Robert G Gish, Ramsey Cheung, et al.Pageof 28